Economic Burden in Non-Hodgkin Lymphoma Survivors: The French Lymphoma Study Association SIMONAL Cross-Sectional Study - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue Année : 2022

Economic Burden in Non-Hodgkin Lymphoma Survivors: The French Lymphoma Study Association SIMONAL Cross-Sectional Study

Gilles Salles

Résumé

No study has focused on the economic burden in non-Hodgkin lymphoma (NHL) survivors, even though this knowledge is essential. This study reports on health care resource use and associated health care costs as well as related factors in a series of 1671 French long-term NHL survivors. METHODS: Health care costs were measured from the payer perspective. Only direct medical costs (medical consultations, outpatient treatments, hospitalizations, and medical transport) in the past 12 months were included (reference year 2015). Multiple linear regression was used to search for explanatory factors of health care costs. RESULTS: In total, 1100 survivors (66%) reported having used at least 1 health care resource, and 867 (52%) reported having used at least 1 outpatient treatment. After the authors accounted for missing data, the mean health care cost was estimated at €702 ± €2221. Hospitalizations and outpatient treatments were the main cost drivers. Sensitivity analyses confirmed the robustness of the results. For the 1100 survivors who reported using at least 1 health care resource, the mean health care cost was €1067 ± €2268. Several factors demonstrated statistically significant relationships with health care costs. For instance, cardiovascular disorders increased costs by 66% ± 16%. In contrast, rituximab or autologous stem cell transplantation as initial therapy had no effect on health care costs. CONCLUSIONS: The consideration of economic constraints in health care is now a reality. This retrospective study reports on a better understanding of health care resource use and associated health care costs as well as related factors. It may help health care professionals in their ongoing efforts to design personcentered health care pathways.
Fichier non déposé

Dates et versions

hal-03692839 , version 1 (10-06-2022)

Identifiants

  • HAL Id : hal-03692839 , version 1

Citer

Virginie Nerich, Christophe Guyeux, Michel Henry-Amar, Raphael Couturier, Catherine Thieblemont, et al.. Economic Burden in Non-Hodgkin Lymphoma Survivors: The French Lymphoma Study Association SIMONAL Cross-Sectional Study. 2022, 128 (3), pp.519 - 528. ⟨hal-03692839⟩
5 Consultations
0 Téléchargements

Partager

Gmail Facebook X LinkedIn More